Search

everythinglearnresearchcommunity

for

Search:↓

Cepharanthine may help treat COVID-19 by targeting similar pathways as other inflammatory diseases.

Certain natural and synthetic compounds may help treat inflammatory skin diseases by targeting a specific signaling pathway.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

Astilbin can potentially calm overactive immune responses, like in Type 1 Diabetes, by suppressing certain cell activities and reducing inflammation.

Alopecia areata is a hair loss condition caused by immune factors and can be treated with JAK inhibitors.

Skin bacteria can help wound healing by activating certain immune cells.

Inflammation plays a key role in activating skin stem cells for hair growth and wound healing, but more research is needed to understand how it directs cell behavior.

Gingerol may help treat chronic graft-versus-host disease by improving immune cell balance.

Activating TRPV1 can boost hair growth by involving neurons, macrophages, and fibroblasts.

The immune processes causing VKH and vitiligo are similar in dogs and humans.

Brepocitinib improves cicatricial alopecia and reduces key immune markers.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

Faulty Notch signalling may cause hair follicle changes and inflammation in hidradenitis suppurativa.

New treatments for seborrheic dermatitis show promise for difficult cases.

Dupilumab and COVID-19 can worsen or trigger psoriasis.

Canine pemphigus foliaceus involves significant immune activity and shares similarities with human pemphigus.

Vitamin A affects hair loss and immune response in alopecia areata.

Anti-EGFR therapy can cause skin issues, but FGF7 treatment might help.

Metabolic syndrome is linked to skin diseases, requiring integrated treatment and monitoring.

Recent findings suggest that genetic factors, immune system issues, and skin cell defects might contribute to the development of hidradenitis suppurativa.

Targeting CD169+ skin macrophages may help treat psoriasis.

Pu-erh tea reduces hair loss risk in offspring.

TSLP affects atopic dermatitis by increasing sebum and reducing fat through IL-4/IL-13 signaling.

Chronic graft-versus-host disease in the skin shows strong Th1 immune response and unique barrier issues.

New treatments for ichthyosis, like protein replacement and gene therapy, show promise and may become standard care.

The study found key factors in the cause of hidradenitis suppurativa, its link to other diseases, and identified existing drugs that could potentially treat it.

New treatments focusing on immune pathways show promise for stubborn hair loss.

Innate lymphoid cells help control skin bacteria by regulating sebaceous glands.

New insights into the causes and treatments for the autoimmune hair loss condition Alopecia areata have been made.

Emerging therapies like JAK inhibitors show promise for hair regrowth in alopecia areata.